TGFB1 and neoplasm: Studies have shown that EVs derived from tumor-associated fibroblasts can enter OC cells promoting migration, invasion and epithelial–mesenchymal transition (EMT) through transformation of TGFβ1-mediated SMAD signaling pathways [92]; therefore, inhibiting the entry of these exosomes into OC cells may be a potential therapeutic approach.